MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image ORBITAL THERAPEUTICS
ORBITAL THERAPEUTICS

ORBITAL THERAPEUTICS

HQ - Cambridge, Massachusetts

Summary

Orbital Therapeutics is leading the future of RNA medicines with a comprehensive technology platform aligned to the complexity of disease biology.

Deals Overview

Total Deals2
Valued Deals2
Total Value£ 1.34 B
Avg. Deal Size£ 672 M

Market Context

Sort

26 Apr 2023|United States|Biotechnology
Orbital Therapeutics
Newpath Partners

Target: ORBITAL THERAPEUTICS

Bidder: NEWPATH PARTNERS

5 Service Providers

3 Target | 2 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 216 M

Value

10 Oct 2025|United States|Biotechnology
Orbital Therapeutics
Bristol Myers Squibb Company

Target: ORBITAL THERAPEUTICS

Bidder: BRISTOL MYERS SQUIBB COMPANY

8 Service Providers

5 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 1.13 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - ORBITAL THERAPEUTICS